Inventor · disambiguated record
Kazunari Akiyoshi
Also filed as: AKIYOSHI KAZUNARI
10 granted patents·12 pending applications·40 citations·filing 1999–2022
85Inventor score
Files withUNIV MIE7AKIYOSHI KAZUNARI3NAT UNIV CORP TOKYO MED & DENT2NOF CORP2UNITED IMMUNITY CO LTD2
Top patents by PatentIndex Score
22 records- 0188US8759322B2Hyaluronic acid derivative and pharmaceutical composition thereofAKIYOSHI KAZUNARI·Filed 2009·Granted Jun 24, 2014·12 cites·30 claims
- 0276US9023384B2Liposome and method for injecting substance to cell using this liposomeMORITA IKUO·Filed 2005·Granted May 5, 2015·1 cites·9 claims
- 0375US8987230B2Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the sameAKIYOSHI KAZUNARI·Filed 2008·Granted Mar 24, 2015·1 cites·17 claims
- 0472US11714068B2Exosome production methodUNIV MIE·Filed 2019·Granted Aug 1, 2023·1 cites·6 claims
- 0570US8961983B2Mucosal vaccine using cationic nanogelNAT UNIV CORP TOKYO MED & DENT·Filed 2014·Granted Feb 24, 2015·2 cites·7 claims
- 0668US11083744B2Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cellsUNIV MIE·Filed 2016·Granted Aug 10, 2021·1 cites·13 claims
- 0767US2022062398A1Long chain antigen containing interepitope sequence that promotes antigen presentation to t cellsUNIV MIE·Filed 2021·Application pending·0 cites
- 0866US11179450B2Long chain antigen containing interepitope sequence that promotes antigen presentation to T cellsUNIV MIE·Filed 2018·Granted Nov 23, 2021·0 cites·23 claims
- 0966US6566516B1High purity polysaccharide containing a hydrophobic group and process for producing itNOF CORP·Filed 1999·Granted May 20, 2003·21 cites·18 claims
- 1064US2011206729A1Mucosal vaccine using cationic nanogelAKIYOSHI KAZUNARI·Filed 2009·Application pending·0 cites
- 1161US9833407B2Nasal vaccine for Streptococcus pneumoniaeLSIP LLC·Filed 2015·Granted Dec 5, 2017·1 cites·4 claims
- 1254US12059471B2ComplexUNITED IMMUNITY CO LTD·Filed 2021·Granted Aug 13, 2024·0 cites·10 claims
- 1354US2016367651A1T cell inducing vaccine containing an interepitope sequence that promotes antigen presentationUNIV MIE·Filed 2014·Application pending·0 cites
- 1450US2024342107A1Cancer therapeutic agentUNITED IMMUNITY CO LTD·Filed 2022·Application pending·0 cites
- 1550US2010221345A1Osteogenic biomaterial containing osteogenesis promoting substance and nanogelNAT UNIV CORP TOKYO MED & DENT·Filed 2007·Application pending·0 cites
- 1647US2019111078A1Pretreatment drug for t cell infusion therapy for immune-checkpoint inhibitor-resistant tumorUNIV MIE·Filed 2017·Application pending·0 cites
- 1746US2022160849A1Cancer vaccine formulationUNIV MIE·Filed 2020·Application pending·0 cites
- 1845US2002143160A1High purity polysaccharide containing hydrophobic group and process for producing itNOF CORP·Filed 2002·Application pending·0 cites
- 1942US2021322531A1Mucosal vaccine composition for bovine mastitisNAT AGRICULTURE & FOOD RES ORG·Filed 2019·Application pending·0 cites
- 2038US2014322344A1Vaccine preparation for cancer treatmentSHIKU HIROSHI·Filed 2012·Application pending·0 cites
- 2132US2007253940A1Composition Comprising Platelet-Rich PlasmaTORAY INDUSTRIES·Filed 2005·Application pending·0 cites
- 2231US2005170327A1Method for preparing platelet-rich plasmaFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kazunari Akiyoshi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →